Skip to content

AACR Annual Meeting 2026

April 17–22, 2026 · San Diego · 2418 items

Over 22,000 attendees and more than 7,400 abstracts, including a record 265 clinical trial abstracts. This section collects on-site analysis across fifteen signal directions, plus late-breaking, clinical-trial and new-drug abstracts.

Page 2 No.21–40

  1. 21

    zanidatamab

    5↓ 29%
  2. 22

    CID-078

    4↓ 29%
  3. 23

    nivolumab

    4↓ 30%
  4. 24

    #ANNUALMEETING

    4↓ 30%
  5. 25

    MK-2010

    4↓ 28%
  6. 26

    #EARLYCAREER

    3↓ 30%
  7. 27

    #CARTCELL

    3↓ 28%
  8. 28

    #LCSM

    3↓ 29%
  9. 29

    #GYNCSM

    2↓ 28%
  10. 30
  11. 31

    adebrelimab

    2↓ 28%
  12. 32

    #MYELOMA

    1↓ 29%
  13. 33

    #CART

    10New
  14. 34
  15. 35

    #MMSM

    9New
  16. 36

    #CITYOFHOPEBuilding

    9↑ 123%
  17. 37

    VS-7375Building

    9↑ 76%
  18. 38

    #CANCERONCHIP

    7↓ 29%
  19. 39

    #CANCERDATA

    6↓ 29%
  20. 40

    MEK

    5↓ 29%
CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org